Steatotic Liver Disease Subtypes and Advanced Fibrosis as Independent Predictors of Ischemic Stroke in Type 2 Diabetes Mellitus
Endocrinology and Metabolism · 18.05.2026
DOI: 10.3803/enm.2025.2792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology and Metabolism, online erschienen am 18.05.2026. Verfasst von Myunghwa Jang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Themen: Diabetes mellitus, Schlaganfall
Abstract (Originalsprache)
Background
Although type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD) are associated with an increased risk of ischemic stroke, the extent to which steatotic liver disease (SLD) subtypes and advanced liver fibrosis confer additional risk in individuals with T2DM remains unclear. We aimed to investigate the association of SLD categories and/or advanced liver fibrosis with ischemic stroke risk among patients with T2DM.
Methods
A total of 2,220,249 patients with T2DM were classified into five groups: no steatosis, MASLD, MASLD with other combined disease, metabolic dysfunction and alcohol-related steatotic liver disease (MetALD), and alcohol-related liver disease (ALD) with metabolic dysfunction (MD). SLD was defined using a fatty liver index (FLI) of ≥30, and advanced fibrosis was defined by a BARD score of ≥2.
Results
Over a median follow-up of 11 years, 135,482 ischemic strokes (6.10%) occurred. Compared with no steatosis, adjusted hazard ratios (aHRs) for stroke were higher in MASLD (aHR, 1.10; 95% confidence interval [CI], 1.08 to 1.11), MASLD with combined disease (aHR, 1.14; 95% CI, 1.12 to 1.17), MetALD (aHR, 1.13; 95% CI, 1.11 to 1.16), and ALD with MD (aHR, 1.32; 95% CI, 1.27 to 1.37). Advanced fibrosis progressively increased stroke risk compared with non-SLD and non-fibrotic SLD. Compared with the FLI
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.
Zitieren
APA
Jang, M., Kim, G., Lee, K. N., Oh, R., Cho, S. H., Kim, J. Y., Lee, Y. B., Jin, S. M., Hur, K. Y., Han, K., & Kim, J. H. (2026). Steatotic Liver Disease Subtypes and Advanced Fibrosis as Independent Predictors of Ischemic Stroke in Type 2 Diabetes Mellitus. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2025.2792
Vancouver
Jang M, Kim G, Lee KN, Oh R, Cho SH, Kim JY, et al. Steatotic Liver Disease Subtypes and Advanced Fibrosis as Independent Predictors of Ischemic Stroke in Type 2 Diabetes Mellitus. Endocrinology and Metabolism. 2026. doi:10.3803/enm.2025.2792
BibTeX
@article{Jang2026,
author = {Jang, Myunghwa and Kim, Gyuri and Lee, Kyu-Na and Oh, Rosa and Cho, So Hyun and Kim, Ji Yoon and Lee, You-Bin and Jin, Sang-Man and Hur, Kyu Yeon and Han, Kyungdo and Kim, Jae Hyeon},
title = {Steatotic Liver Disease Subtypes and Advanced Fibrosis as Independent Predictors of Ischemic Stroke in Type 2 Diabetes Mellitus},
journal = {Endocrinology and Metabolism},
year = {2026},
doi = {10.3803/enm.2025.2792}
}
EUVIMED